Genworth Financial (GNW) Q4 2024 earnings summary

Executive summary

• Celebrated 20th IPO anniversary, highlighting progress on debt reduction, share repurchases, and CareScout expansion to all 50 states, covering 86% of the U.S. 65+ population.

• Ended 2024 with $790M in holding company debt, down from $4.2B in 2013, and reduced outstanding shares by 18% since 2022.

• Achieved $40M in incremental LTC premium approvals in Q4 and $343M for 2024, with $31.2B NPV from in-force rate actions since 2012.

• Returned $51M to shareholders via Q4 share repurchases; $565M program-to-date, and repurchased $31M in holding company debt at a discount.

• Completed annual assumption updates with $52M unfavorable impact to adjusted operating income in LTC and Life & Annuities.

Financial highlights

• Q4 2024 net loss of $1M and adjusted operating income of $15M; full-year net income of $299M and adjusted operating income of $273M.

• Enact contributed $137M in Q4 and $585M for the year to adjusted operating income, with $84M in capital returns in Q4.

• U.S. life insurance companies had a Q4 pre-tax statutory loss of $33M but full-year pre-tax income of $378M, with RBC ratio at 306%.

• Net investment income rose to $626M in Q4, up from $614M in Q3, driven by limited partnerships.

• Holding company cash and liquid assets at year-end were $294M.

Outlook and guidance

• Plans to invest $45-$50M in CareScout Services and $75M in a new CareScout Insurance Company in 2025.

• Anticipate $100-$120M allocated to share repurchases in 2025, subject to market conditions.

• CareScout to launch a new LTC insurance company and expand its Quality Network and tech-enabled platform.

• Ongoing focus on achieving remaining $4.6B in MYRAP value and further benefit reductions to manage LTC risk.

• Management expects continued focus on LTC rate actions, capital returns, and scaling CareScout.